ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

HALO Halozyme Therapeutics Incorporated

42,56
-1,28 (-2,92%)
11 Mai 2024 - Fermé
Retardé de 15 minutes
Quarter End Mar 2022Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 117,28M152,37M208,98M181,5M162,14M221,04M216,03M230,04M
Revenu d'exploitation 75,67M34,06M63,19M74,51M53,8M94,46M88,28M101,04M
Revenu avant impôt 74,41M30,01M73,71M70,79M52,24M93,16M101,76M101,18M
Revenu net 60,11M22,69M61,63M57,7M39,62M74,75M81,84M85,39M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT 76,17M33,61M60,93M74,51M53,8M94,46M88,28M101,04M
EBITDA 76,45M46,61M92,4M81,62M74,26M115,09M111,36M121,73M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 146,69M316,61M151,86M195,99M267,59M443,31M660,12M829,25M
Revenu d'exploitation -83,21M81M-69,33M-67,61M144,26M275,9M267,53M337,57M
Revenu avant impôt -101,86M61,61M-79,79M-72,25M129,3M248,52M248,92M348,33M
Revenu net -103,02M62,97M-80,33M-72,24M129,09M402,71M202,13M281,59M
Dividendes privilégiés 00000000
Résultat de base par action -0.7480.417-0.525-0.4990.9012.7641.412.007
EBIT -83,21M81M-61,75M-60,62M149,68M254,94M264,82M337,57M
EBITDA -80,8M83,16M-66,94M-63,54M147,54M278,9M317,17M422,43M

Dernières Valeurs Consultées